Patent · US Active

Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain

US8815810B2 · kind B2 · utility

1Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2013
Grant dateAug 26, 2014
Priority date
Expiry dateMar 14, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2035/126
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of Meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain. In a preferred embodiment the disorder to be treated is allodynia, and hyperalgesia, more preferably allodynia including thermal and tactile allodynia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.